Navigation Links
Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty
Date:12/16/2011

BOSTON, Dec. 16, 2011 /PRNewswire/ -- Block & Leviton LLP is investigating whether the Board of Directors of ISTA Pharmaceuticals, Inc. ("ISTA" or the "Company") (NASDAQ: ISTA) breached their fiduciary duties by rejecting an offer from Valeant Pharmaceuticals International, Inc. ("Valeant") (NASDAQ: VRX) to acquire the Company in a proposed transaction valued at $327 million. 

The investigation centers on whether ISTA's Board of Directors protected shareholder interests, and properly maximized shareholder value, when it refused Valeant's offer to acquire the Company for approximately $6.50 per share, representing a hefty premium to ISTA's shareholders of approximately 67% over the stock's closing price of $3.89 on December 15, 2011. 

If you own stock in ISTA and want to discuss your rights with regard to ISTA's rejection of the Valeant offer, or if you have any questions, please contact Mark Alan Delaney at (617) 398-5650 or Mark@blockesq.com

The attorneys at Block & Leviton LLP have more than 40 years of experience in representing individual and institutional investors in shareholder rights actions and throughout their careers have achieved significant recoveries for their clients.

This may constitute attorney advertising.


'/>"/>
SOURCE Block & Leviton LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Indiana Stop-Sale System Shows Effectiveness of Real-Time, Blocking Technology in the Fight Against Illegal Sales of Pseudoephedrine
2. Alabama Stop-Sale System Blocks Illegal Sales & Allows Legal Ones
3. DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill" Catheterization Technique to Remove a Major Blockage
4. NADDI Lauds Ohio Bill Introduction: Real-Time, Stop-Sale System Blocks Illegal Sales
5. Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
6. FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer
7. For Treatment of Irritable Bowel Syndrome, Linaclotide Will Emerge as the Market Leader and Will Achieve Blockbuster Status in 2019
8. NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of AMP Rule Currently Blocked by Injunction
9. Amedica® Receives Patent for Knee Prosthesis With Monoblock Silicon Nitride Ceramic Tibial Component
10. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
11. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 19, 2017 Report Details ... Which areas are going to grow at the fastest ... 2026, assessing data, trends, opportunities and prospects. Our ... the most lucrative areas in the industry and the ... forecasted sales across the all the major categories of ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh has posted a new publication this ... generation is a time like no other and society needs to understand the only way ... does not want to sound like an old bible beater because religion has a bad ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a ... percent pure essential oils, announced the company had a successful visit to the 2017 ... ECRM event gives companies that work in the nutritional, sports and health industries a ...
(Date:1/20/2017)... ... January 20, 2017 , ... Doctor C LLC, a company based out ... trade show to continue the marketing and distribution of its product, The Right C. ... 400 percent better absorption than traditional vitamin C supplements. At the trade show, Doctor ...
(Date:1/20/2017)... ... ... Bionic Sports Nutrition LLC, an American company devoted to developing high-quality nutritional ... ECRM Trade Show in Hilton Head, SC. , Bionic Sports Nutrition manufactures its ... products to all clients at reasonable prices. At the ECRM trade show, it had ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice removal company based ... school-aged children since the holiday season. , “It happens every year around this ... hugs and taking photos, which is the head-to-head gateway that lice need to spread.” ...
Breaking Medicine News(10 mins):